TickerFacts.

Company research / INBS

INTELLIGENT BIO SOLUTIONS INC. (INBS)

Build a valuation ↗↓ Download CSV

CIK 0001725430 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, INTELLIGENT BIO SOLUTIONS INC. reported revenue of $4.22M. Revenue grew 38.1% from the prior annual period.

Key ratios (year ended 2026-06-30)

48.6%
Gross margin
-299.1%
Operating margin
-294.9%
Net margin
-225.6%
Return on year-end equity
38.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-30
Revenue$4.22M$3.05M$3.11M$1.26M$437.1K$1.98M——
Cost of Revenue$2.17M$1.81M$1.69M$930.2K————
Gross Profit$2.05M$1.25M$1.43M$326.7K————
Operating Income-$12.61M-$10.68M-$10.28M-$12.60M-$8.34M-$5.57M-$2.86M—
Net Income-$12.43M-$10.57M-$10.16M-$10.63M-$8.31M-$7.04M-$3.16M—
EPS (Diluted)$-8.44$-20.04$-6.38$-127.00$-11.33———
Total Assets$11.94M$8.25M$13.78M$10.35M$12.35M$21.86M$2.48M—
Total Liabilities$6.65M$5.44M$5.60M$6.67M$5.81M$6.85M$7.69M—
Shareholders' Equity$5.51M$3.00M$8.33M$3.80M$6.62M$15.06M-$5.19M-$3.98M
Cash & Equivalents$3.99M$1.02M$6.30M$1.54M$8.24M$12.57M$427.3K—
Operating Cash Flow-$11.93M-$9.68M-$9.57M-$7.38M-$3.36M-$11.30M-$498.6K—
Capital Expenditures$125.7K$231.8K$221.4K—————
Shares Outstanding2.91M732.3K3.46M194.2K14.89M13.58M8.63M—
Weighted Average Diluted Shares1.47M527.4K1.59M83.7K733.3K———
EPS (Basic)$-8.44$-20.04$-6.38$-127.00$-11.33$-0.68——